GlaxoSmithKline (GSK) is a world-leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in todayÔÇÖs rapidly changing healthcare environment.
GSKÔÇÖs mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
Headquartered in the UK and with operations based in the US, the company is one of the industry leaders, with an estimated seven per cent of the worldÔÇÖs pharmaceutical market.
GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.
The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products, and nutritional healthcare drinks, all of which are among the market leaders.
Based on 2003 Annual Results, GSK had sales of ┬ú21.4 billion (US$35.2 billion) and profit before tax of ┬ú6.7 billion (US$11 billion). Total pharmaceutical turnover grew 5% to just over ┬ú18 billion (US$29 billion).
GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Almost 42,000 employees work at 99 manufacturing sites in 39 countries and over 16,000 are in research and development (R&D).
GSK R&D has over 16,000 employees based at 24 sites in seven countries.The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about ┬ú2.4 billion/US$4 billion.
GlaxoSmithKlineÔÇÖs broad pharmaceutical product line includes antibiotic, antidepressant, gastrointestinal, dermatological, respiratory, cancer, and cardiovascular medications. GSK has a wide variety of vaccine products, including hepatitis A and B, diphtheria, tetanus, and whooping cough and influenza.